Kalaris Therapeutics, Inc. (KLRS) › EPS (Basic)Kalaris Therapeutics, Inc. (KLRS) — EPS (Basic)Annual figures by period end, from SEC filings.2021-12-31: $-2.742022-12-31: $-2.202023-12-31: $-42.092024-12-31: $-51.772025-12-31: $-2.85$-2.852021-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-2.85—2026-03-17From 2025-01-012024-12-31$-51.77—2026-03-17From 2024-01-012023-12-31$-42.09—2025-03-07From 2023-01-012022-12-31$-2.20—2024-03-15From 2022-01-012021-12-31$-2.74—2023-02-15From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares